Works matching DE "ESTROGEN receptors"

Results: 5000
    1
    2
    3
    4
    5
    6
    7
    8
    9
    10
    11

    Integrated Nanopore and short-read RNA sequencing identifies dysregulation of METTL3- m6A modifications in endocrine therapy- sensitive and resistant breast cancer cells.

    Published in:
    Functional & Integrative Genomics, 2025, v. 25, n. 1, p. 1, doi. 10.1007/s10142-025-01658-2
    By:
    • Petri, Belinda J.;
    • Piell, Kellianne M.;
    • Avila-Valdes, Bailey L.;
    • Stanley, Christian G.;
    • Winkler, Laura J.;
    • Brown, Johnny Tyler;
    • Ulett, Rye;
    • Sanchez, Gabriela;
    • Chariker, Julia H.;
    • Rouchka, Eric C.;
    • Klinge, Carolyn M.
    Publication type:
    Article
    12
    13
    14
    15
    16

    Integrating PET/CT into breast cancer care: a review of recent developments.

    Published in:
    Expert Review of Anticancer Therapy, 2025, v. 25, n. 7, p. 771, doi. 10.1080/14737140.2025.2513450
    By:
    • Moghrabi, Serin;
    • Mohammad Al-Houwari, Raghad;
    • Abdel-Razeq, Hikmat;
    • Mansour, Asem;
    • Mikhail-Lette, Miriam;
    • Abdlkadir, Ahmed Saad;
    • Ruzzeh, Saad;
    • Paez, Diana;
    • Marton, Christopher;
    • Al-Ibraheem, Akram
    Publication type:
    Article
    17
    18
    19
    20
    21
    22
    23

    Palazestrant, a novel oral Complete Estrogen Receptor Antagonist (CERAN) and Selective Estrogen Receptor Degrader (SERD), in patients with ER+/HER2− advanced or metastatic breast cancer: phase 1/2 study results.

    Published in:
    Breast Cancer Research, 2025, v. 27, n. 1, p. 1, doi. 10.1186/s13058-025-02049-y
    By:
    • Hamilton, Erika P.;
    • Patel, Manish R.;
    • Borges, Virginia F.;
    • Meisel, Jane L.;
    • Okera, Meena;
    • Alemany, Carlos A.;
    • Pluard, Timothy J.;
    • Wesolowski, Robert;
    • Sabanathan, Dhanusha;
    • Miller, Kathy D.;
    • Conlin, Alison K.;
    • McCarthy, Nicole;
    • Shaw, Morena;
    • Tonda, Margaret;
    • Shilkrut, Mark;
    • Lin, Nancy U.
    Publication type:
    Article
    24

    Pre-existing and emerging immune-mediated diseases in patients with breast cancer undergoing cyclin-dependent kinases 4/6 inhibitors and endocrine therapy.

    Published in:
    Oncologist, 2025, v. 30, n. 6, p. 1, doi. 10.1093/oncolo/oyaf123
    By:
    • Jacobs, Flavia;
    • Gaudio, Mariangela;
    • Andreottola, Chiara;
    • Borroni, Riccardo;
    • Benvenuti, Chiara;
    • Saltalamacchia, Giuseppe;
    • Gerosa, Riccardo;
    • Canzian, Jacopo;
    • Tiberio, Paola;
    • Torrisi, Rosalba;
    • Masci, Giovanna;
    • Miggiano, Chiara;
    • Zambelli, Alberto;
    • Santoro, Armando;
    • Sanctis, Rita De
    Publication type:
    Article
    25

    Establishment and molecular characterization of novel luminal A and luminal B canine mammary cancer cell lines for comparative oncology.

    Published in:
    Veterinary World, 2025, v. 18, n. 6, p. 1725, doi. 10.14202/vetworld.2025.1725-1740
    By:
    • Juthathip Jurutha;
    • Yanika Piyasanti;
    • Kornkanok Sritabtim;
    • Suparat Chaipipat;
    • Kannika Siripattarapravat;
    • Sukumal Prukudom;
    • Usuma Jermnak;
    • Rungthiwa Sinsiri;
    • Kakanang Wongsuppabut;
    • Charuwan Wongsali;
    • Nutawan Niyatiwatchanchai;
    • Wijit Sutthiprapa;
    • Napachanok Swainson;
    • Wachiraphan Supsavhad
    Publication type:
    Article
    26
    27
    28
    29
    30
    31
    32
    33
    34
    35
    36
    37
    38
    39
    40
    41
    42
    43
    44
    45
    46
    47
    48
    49
    50